Evidence map›Paper›PMID 35636827›Full record

ReviewClinics in laboratory medicine2022

Approaches to Deployment of Molecular Testing for SARS-CoV-2 in Resource-Limited Settings.

Gama Bandawe, Moses Chitenje, Joseph Bitiliyu-Bangoh, Elizabeth Kampira

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Clinics in laboratory medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Gama BandaweBiological Sciences Department, Academy of Medical Sciences, Malawi University of Science and Technology, P. O. Box 5196, Limbe, Malawi. Electronic address: gbandawe@must.ac.mw.
Moses ChitenjeInternational Teaching and Education Centre for Health (ITECH), PO Box 30369, Capital City Lilongwe 3, Plot 13/14, 1st Floor ARWA House, City Center, Lilongwe, Malawi; Public Health Institute of Malawi, Ministry of Health, Lilongwe, Malawi.
Joseph Bitiliyu-BangohMinistry of Health, P.O. Box 30377, Lilongwe 3, Malawi.
Elizabeth KampiraCentres for Disease Control and Prevention, P. O. Box 30016, NICO House, City Centre, Lilongwe 3, Lilongwe, Malawi.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Deployment of molecular testing for SARS-CoV-2 in resource-limited settings is challenging. Scale-up of molecular had to be conducted with a laboratory system strengthening approach that emphasize laboratory integration. National reference laboratories play a central role. In Malawi the molecular testing was underpinned by existing pathogen control programs for human immunodeficiency virus and tuberculosis that use Abbott and GeneXpert machines and reagents. Despite this, the impact on these programs was well managed. Antigen testing increased access to testing. Pooled testing and direct-to-polymerase chain reaction methods have the potential to save costs and further increase access to molecular tests.

Indexed as

COVID-19HIV InfectionsHumansMolecular Diagnostic TechniquesPolymerase Chain ReactionSARS-CoV-2Cost reductionLaboratory strengtheningMolecular testingNational reference laboratorySARS-CoV-2

Identifiers

PMID35636827
PMCPMC8885302

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.